Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of alternate formulation of aripiprazole in agitated patients with schizophrenic disorders

Trial Profile

Study of alternate formulation of aripiprazole in agitated patients with schizophrenic disorders

Completed
Phase of Trial: Phase II/III

Latest Information Update: 01 Feb 2007

At a glance

  • Drugs Aripiprazole; Haloperidol
  • Indications Agitation; Psychotic disorders; Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Feb 2007 Results have been presented.
    • 16 Nov 2006 Status change
    • 09 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top